Bristol-Myers Squibb Co (BMY)

Industry Drug Manufacturers - General
This stock can be held in an Investment ISA and an Investment Account
Sell

$48.24

Buy

$48.30

arrow-up$0.41 (+0.86%)

Prices updated at 31 May 2025, 00:56 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Bristol-Myers Squibb Co is engaged in discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceuticals products. The company operates in one segment that is Biopharmaceuticals.
S&P 500
arrow-down-0.01%
NYSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Drug Manufacturers - General
Chairman
Dr. Christopher S. Boerner, PhD
CEO
Dr. Christopher S. Boerner, PhD
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
34,100
Head office
Route 206 and Province Line Road
New Jersey
United States
08543
mobile
+1 609 252-4621
letter
timothy.power@bms.com
computer
Company website

Key personnel

Owner name
chevron-l-regular
chevron-r-regular
Salary
Ms. Sandra Leung
Executive Vice President and General Counsel
1.15m
Mr. Derica W. Rice
Independent Director
0.15m
Mr. Michael R. McMullen
Independent Director
0.06m
Ms. Phyllis R. Yale
Independent Director
0.14m
Ms. Paula A. Price
Independent Director
0.14m
Mr. Peter J. Arduini
Independent Director
0.14m
Mr. David V. Elkins
Executive Vice President and Chief Financial Officer
1.12m
Dr. Christopher S. Boerner, PhD
Chairman of the Board and Chief Executive Officer
1.54m
Dr. Julia A. Haller, M.D.
Independent Director
0.15m
Mr. Theodore R. Samuels
Lead Independent Director
0.20m
Dr. Karen H. Vousden, PhD
Independent Director
0.14m
Mr. Benjamin J. Hickey, M.B.A.
President, RayzeBio Organization
-
Dr. Robert M. Plenge, M.D.,PhD
Executive Vice President, Chief Research Officer and Head of Research
-
Dr. Samit Hirawat, M.D.
Executive Vice President, Chief Medical Officer and Head of Development
1.12m
Dr. Manuel Hidalgo Medina, M.D.,PhD
Independent Director
0.14m
Mr. Gregory Scott Meyers
Executive Vice President, Chief Digital Officer and Chief Technology Officer
-
Ms. Karin Shanahan
Executive Vice President, Global Product Development and Supply
1.01m
Dr. Deepak L. Bhatt, M.D.,M.P.H.
Independent Director
0.14m
Mr. Adam Lenkowsky
Executive Vice President and Chief Commercialization Officer
-
Ms. Cari Gallman
Executive Vice President, Corporate Affairs
-
Ms. Lynelle Hoch
President, Cell Therapy Organization
-
Ms. Amanda Ahn Poole
Executive Vice President and Chief People Officer
-
Mr. Phil Holzer
Senior Vice President, Principal Accounting Officer and Controller
-

Top 5 shareholders

Owner name
chevron-l-regular
chevron-r-regular
No. of shares
Vanguard Group Inc191,403,004
BlackRock Inc161,366,354
JPMorgan Chase & Co108,052,504
State Street Corp94,834,478
Capital Research & Mgmt Co - Division 366,465,773

Director dealings

Date
chevron-l-regular
chevron-r-regular
Action
31 Dec 2024-
31 Dec 2024-
31 Dec 2024-
31 Dec 2024-
31 Dec 2024-
04 Nov 2024-
01 Nov 2024-
01 Nov 2024-
01 Nov 2024-
01 Nov 2024-
01 Nov 2024-
01 Nov 2024-
01 Nov 2024-
02 Oct 2024-
02 Oct 2024-
02 Oct 2024-
30 Sep 2024-
30 Sep 2024-
30 Sep 2024-
30 Sep 2024-
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.